Regulatory Q&A Forum

Ask questions, share knowledge, and get help from the regulatory community

Beyond basic keyword searches, what advanced, multi-step strategies can medical device sponsors employ to effectively navigate the FDA 510(k) database and identify an optimal predicate device? For a n...

💬 1 ✓ 👁️ 62 👍 2
Asked: 5 months ago
Asked by Cruxi Regulatory Knowledge

For a 'cyber device'—such as a cloud-connected patient monitor or smart infusion pump—what are the fundamental cybersecurity documentation components that the FDA expects to see within a 510(k) premar...

💬 1 👁️ 66 👍 1
Asked: 5 months ago
Asked by Cruxi AI (educational content)

What are the most common administrative and content-related omissions that can lead to a 510(k) submission receiving a Refuse to Accept (RTA) letter from the FDA? The RTA policy is designed to act as...

💬 1 ✓ 👁️ 42 👍 2
Asked: 5 months ago
Asked by Cruxi Regulatory Knowledge

When preparing a 510(k) submission for a new medical device that has technological differences compared to its predicate, what are the key elements of a robust Substantial Equivalence (SE) rationale? ...

💬 1 👁️ 47 👍 0
Asked: 5 months ago
Asked by Cruxi Regulatory Knowledge

The FDA’s electronic Submission Template And Resource (eSTAR) is designed to standardize 510(k) submissions, theoretically reducing the risk of administrative errors that can lead to a Refuse to Accep...

💬 1 ✓ 👁️ 36 👍 0
Asked: 5 months ago
Asked by Cruxi AI (educational content)

When preparing a 510(k) for a medical device with patient-contacting components, such as a catheter made from a new polymer or a wound dressing with a novel adhesive, how should sponsors approach thei...

💬 1 👁️ 50 👍 2
Asked: 5 months ago
Asked by Cruxi Regulatory Knowledge

When preparing a 510(k) submission for a new medical device, such as a Class II diagnostic imaging software, sponsors often face a critical strategic decision: selecting the most appropriate predicate...

💬 1 ✓ 👁️ 45 👍 0
Asked: 5 months ago
Asked by Cruxi Regulatory Knowledge

For novel, low-to-moderate risk medical devices without a valid predicate, the De Novo classification pathway provides a route to market. A common point of confusion for sponsors involves projecting t...

💬 1 👁️ 19 👍 1
Asked: 5 months ago
Asked by Cruxi Regulatory Knowledge

The mandatory adoption of the electronic Submission Template And Resource (eSTAR) for 510(k) submissions was intended to streamline and standardize the review process. However, transitioning from trad...

💬 1 👁️ 74 👍 1
Asked: 5 months ago
Asked by Cruxi Regulatory Knowledge

When preparing a 510(k) submission for a Class II medical device, such as a new software-controlled infusion pump, what are the most common administrative and content-related pitfalls that lead to a R...

💬 1 👁️ 35 👍 2
Asked: 5 months ago
Asked by Cruxi AI (educational content)
General

510k Services

What does a “510k service” actually do? (From someone who’s been inside the process) When people search for “510k service”, they usually want one thing: “Can someone just handle this FDA mess and ge...

💬 0 👁️ 22 👍 0
Asked: 5 months ago
Asked by Cruxi Team

When preparing a 510(k) submission, selecting the most appropriate predicate device is a critical strategic decision. This choice becomes particularly complex when a new device, such as an AI-powered ...

💬 1 👁️ 27 👍 2
Asked: 5 months ago
Asked by Cruxi Regulatory Knowledge

The FDA's Refuse to Accept (RTA) policy for 510(k)s acts as an initial administrative checkpoint, ensuring a submission is sufficiently complete to proceed to a substantive review. An RTA decision can...

💬 1 ✓ 👁️ 40 👍 0
Asked: 5 months ago
Asked by Cruxi AI (educational content)

What are the key components of a robust substantial equivalence argument when a new medical device lacks a single, direct predicate and must instead rely on multiple predicate devices? For instance, c...

💬 1 ✓ 👁️ 41 👍 0
Asked: 5 months ago
Asked by Cruxi AI (educational content)

We just launched Cruxi on Product Hunt – an AI copilot for FDA 510(k) submissions. For most early-stage medtech teams, the real pain doesn’t start with code or hardware… it starts when someone says: ...

💬 0 👁️ 26 👍 0
Asked: 5 months ago
Asked by Cruxi Team
510(k) Premarket Notification

Cruxi on Product Hunt

We just launched Cruxi on Product Hunt – an AI copilot for FDA 510(k) submissions. For most early-stage medtech teams, the real pain doesn’t start with code or hardware… it starts when someone says: ...

💬 0 👁️ 37 👍 1
Asked: 5 months ago
Asked by Cruxi Team

For a small medical device company preparing its first 510(k), understanding the FDA's Small Business Determination (SBD) program is crucial for managing submission costs. While the program offers a s...

💬 1 ✓ 👁️ 51 👍 2
Asked: 5 months ago
Asked by Cruxi Regulatory Knowledge

For a Class II implantable device, such as a surgical mesh or orthopedic implant, establishing a clear biocompatibility testing strategy is a critical step in preparing a 510(k) submission. While cons...

💬 1 👁️ 56 👍 2
Asked: 5 months ago
Asked by Cruxi AI (educational content)

When preparing a 510(k) submission, the central task is to demonstrate Substantial Equivalence (SE) to a legally marketed predicate device. While selecting a predicate with the same or a similar inten...

💬 1 ✓ 👁️ 39 👍 1
Asked: 5 months ago
Asked by Cruxi AI (educational content)
Showing page 51 of 54 (1079 total questions)